44 results on '"Shaykhiev R"'
Search Results
2. Reconstruction of Patient-Specific Distal Airway Regeneration Patterns in COPD
- Author
-
Mahjour, S.B., primary, Gomi, K., additional, Rustam, S., additional, Dolma, P., additional, Krishnan, J., additional, Bareja, R., additional, Hu, Y., additional, Elemento, O., additional, Zhang, T., additional, Xiang, J., additional, Urso, A., additional, D'Ovidio, F., additional, Randell, S.H., additional, Richmond, B.W., additional, Polosukhin, V.V., additional, Blackwell, T.S., additional, and Shaykhiev, R., additional
- Published
- 2019
- Full Text
- View/download PDF
3. Reprogramming of Apical Junctional Complex Assembly in the Small Airway Epithelium of Smokers with COPD.
- Author
-
Shaykhiev, R, primary, Salit, J, additional, and Crystal, RG, additional
- Published
- 2009
- Full Text
- View/download PDF
4. The human endogenous antibiotic LL-37 promotes growth of lung cancer cells
- Author
-
Haussen, J von, primary, Koczulla, R, additional, Shaykhiev, R, additional, Herr, C, additional, Aigner, A, additional, Czubayko, F, additional, and Bals, R, additional
- Published
- 2007
- Full Text
- View/download PDF
5. Das menschliche endogene antibiotische LL-37 fördert das Wachstum von Lungenkrebszellen
- Author
-
Haussen, J von, primary, Koczulla, R, additional, Shaykhiev, R, additional, Aigner, A, additional, Czubayko, F, additional, and Bals, R, additional
- Published
- 2007
- Full Text
- View/download PDF
6. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands
- Author
-
Kandler, K., primary, Shaykhiev, R., additional, Kleemann, P., additional, Klescz, F., additional, Lohoff, M., additional, Vogelmeier, C., additional, and Bals, R., additional
- Published
- 2006
- Full Text
- View/download PDF
7. The Human Endogenous Antimicrobial Peptide Ll-37 Stimulates Airway Epithelial Repair
- Author
-
Shaykhiev, R, primary, Beißwenger, C, additional, Kändler, K, additional, Senske, J, additional, Püchner, A, additional, Damm, T, additional, Behr, J, additional, and Bals, R, additional
- Published
- 2006
- Full Text
- View/download PDF
8. RNA-Seq quantification of the human small airway epithelium transcriptome
- Author
-
Hackett Neil R, Butler Marcus W, Shaykhiev Renat, Salit Jacqueline, Omberg Larsson, Rodriguez-Flores Juan L, Mezey Jason G, Strulovici-Barel Yael, Wang Guoqing, Didon Lukas, and Crystal Ronald G
- Subjects
Biotechnology ,TP248.13-248.65 ,Genetics ,QH426-470 - Abstract
Abstract Background The small airway epithelium (SAE), the cell population that covers the human airway surface from the 6th generation of airway branching to the alveoli, is the major site of lung disease caused by smoking. The focus of this study is to provide quantitative assessment of the SAE transcriptome in the resting state and in response to chronic cigarette smoking using massive parallel mRNA sequencing (RNA-Seq). Results The data demonstrate that 48% of SAE expressed genes are ubiquitous, shared with many tissues, with 52% enriched in this cell population. The most highly expressed gene, SCGB1A1, is characteristic of Clara cells, the cell type unique to the human SAE. Among other genes expressed by the SAE are those related to Clara cell differentiation, secretory mucosal defense, and mucociliary differentiation. The high sensitivity of RNA-Seq permitted quantification of gene expression related to infrequent cell populations such as neuroendocrine cells and epithelial stem/progenitor cells. Quantification of the absolute smoking-induced changes in SAE gene expression revealed that, compared to ubiquitous genes, more SAE-enriched genes responded to smoking with up-regulation, and those with the highest basal expression levels showed most dramatic changes. Smoking had no effect on SAE gene splicing, but was associated with a shift in molecular pattern from Clara cell-associated towards the mucus-secreting cell differentiation pathway with multiple features of cancer-associated molecular phenotype. Conclusions These observations provide insights into the unique biology of human SAE by providing quantit-ative assessment of the global transcriptome under physiological conditions and in response to the stress of chronic cigarette smoking.
- Published
- 2012
- Full Text
- View/download PDF
9. A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease.
- Author
-
Rustam S, Hu Y, Mahjour SB, Rendeiro AF, Ravichandran H, Urso A, D'Ovidio F, Martinez FJ, Altorki NK, Richmond B, Polosukhin V, Kropski JA, Blackwell TS, Randell SH, Elemento O, and Shaykhiev R
- Subjects
- Humans, Lung, Bronchioles, Diagnostic Imaging, CD8-Positive T-Lymphocytes, Pulmonary Disease, Chronic Obstructive
- Abstract
Rationale: Remodeling and loss of distal conducting airways, including preterminal and terminal bronchioles (pre-TBs/TBs), underlie progressive airflow limitation in chronic obstructive pulmonary disease (COPD). The cellular basis of these structural changes remains unknown. Objectives: To identify biological changes in pre-TBs/TBs in COPD at single-cell resolution and determine their cellular origin. Methods: We established a novel method of distal airway dissection and performed single-cell transcriptomic profiling of 111,412 cells isolated from different airway regions of 12 healthy lung donors and pre-TBs of 5 patients with COPD. Imaging CyTOF and immunofluorescence analysis of pre-TBs/TBs from 24 healthy lung donors and 11 subjects with COPD were performed to characterize cellular phenotypes at a tissue level. Region-specific differentiation of basal cells isolated from proximal and distal airways was studied using an air-liquid interface model. Measurements and Main Results: The atlas of cellular heterogeneity along the proximal-distal axis of the human lung was assembled and identified region-specific cellular states, including SCGB3A2
+ SFTPB+ terminal airway-enriched secretory cells (TASCs) unique to distal airways. TASCs were lost in COPD pre-TBs/TBs, paralleled by loss of region-specific endothelial capillary cells, increased frequency of CD8+ T cells normally enriched in proximal airways, and augmented IFN-γ signaling. Basal cells residing in pre-TBs/TBs were identified as a cellular origin of TASCs. Regeneration of TASCs by these progenitors was suppressed by IFN-γ. Conclusions: Altered maintenance of the unique cellular organization of pre-TBs/TBs, including loss of the region-specific epithelial differentiation in these bronchioles, represents the cellular manifestation and likely the cellular basis of distal airway remodeling in COPD.- Published
- 2023
- Full Text
- View/download PDF
10. Author Correction: Unsupervised discovery of tissue architecture in multiplexed imaging.
- Author
-
Kim J, Rustam S, Mosquera JM, Randell SH, Shaykhiev R, Rendeiro AF, and Elemento O
- Published
- 2022
- Full Text
- View/download PDF
11. Unsupervised discovery of tissue architecture in multiplexed imaging.
- Author
-
Kim J, Rustam S, Mosquera JM, Randell SH, Shaykhiev R, Rendeiro AF, and Elemento O
- Subjects
- Humans, Diagnostic Imaging, Transcriptome
- Abstract
Multiplexed imaging and spatial transcriptomics enable highly resolved spatial characterization of cellular phenotypes, but still largely depend on laborious manual annotation to understand higher-order patterns of tissue organization. As a result, higher-order patterns of tissue organization are poorly understood and not systematically connected to disease pathology or clinical outcomes. To address this gap, we developed an approach called UTAG to identify and quantify microanatomical tissue structures in multiplexed images without human intervention. Our method combines information on cellular phenotypes with the physical proximity of cells to accurately identify organ-specific microanatomical domains in healthy and diseased tissue. We apply our method to various types of images across healthy and disease states to show that it can consistently detect higher-level architectures in human tissues, quantify structural differences between healthy and diseased tissue, and reveal tissue organization patterns at the organ scale., (© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
12. Airway Basal Cells in Chronic Obstructive Pulmonary Disease: A Continuum or a Dead End?
- Author
-
Shaykhiev R
- Subjects
- Humans, Lung, Pulmonary Disease, Chronic Obstructive
- Published
- 2021
- Full Text
- View/download PDF
13. Basal-like Cells in the BAL Fluid: An Echo of Regenerative Crisis in Idiopathic Pulmonary Fibrosis Lungs.
- Author
-
Shaykhiev R
- Subjects
- Humans, Lung, Idiopathic Pulmonary Fibrosis
- Published
- 2019
- Full Text
- View/download PDF
14. Emerging biology of persistent mucous cell hyperplasia in COPD.
- Author
-
Shaykhiev R
- Subjects
- Epithelial Cells, Goblet Cells, Humans, Hyperplasia, Receptor, Notch3, Pulmonary Disease, Chronic Obstructive, Rhinovirus
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2019
- Full Text
- View/download PDF
15. At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.
- Author
-
Martinez FJ, Han MK, Allinson JP, Barr RG, Boucher RC, Calverley PMA, Celli BR, Christenson SA, Crystal RG, Fagerås M, Freeman CM, Groenke L, Hoffman EA, Kesimer M, Kostikas K, Paine R 3rd, Rafii S, Rennard SI, Segal LN, Shaykhiev R, Stevenson C, Tal-Singer R, Vestbo J, Woodruff PG, Curtis JL, and Wedzicha JA
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive diagnosis, Pulmonary Disease, Chronic Obstructive physiopathology, Age of Onset, Disease Progression, Early Diagnosis, Pulmonary Disease, Chronic Obstructive classification, Pulmonary Disease, Chronic Obstructive therapy
- Published
- 2018
- Full Text
- View/download PDF
16. Update in Chronic Obstructive Pulmonary Disease 2017.
- Author
-
Zhang WZ, Gomi K, Mahjour SB, Martinez FJ, and Shaykhiev R
- Subjects
- Adult, Aged, Aged, 80 and over, Female, History, 20th Century, History, 21st Century, Humans, Male, Middle Aged, Biomarkers blood, Pulmonary Disease, Chronic Obstructive history, Pulmonary Disease, Chronic Obstructive physiopathology, Pulmonary Disease, Chronic Obstructive therapy
- Published
- 2018
- Full Text
- View/download PDF
17. Airway Epithelial Progenitors and the Natural History of Chronic Obstructive Pulmonary Disease.
- Author
-
Shaykhiev R
- Subjects
- Humans, Respiratory System, Stem Cells, Pulmonary Disease, Chronic Obstructive
- Published
- 2018
- Full Text
- View/download PDF
18. Reply: Epithelial-Mesenchymal Transition: A Necessary New Therapeutic Target in Chronic Obstructive Pulmonary Disease?
- Author
-
Yang J and Shaykhiev R
- Subjects
- Humans, Epithelial-Mesenchymal Transition, Pulmonary Disease, Chronic Obstructive
- Published
- 2017
- Full Text
- View/download PDF
19. Smoking-Dependent Distal-to-Proximal Repatterning of the Adult Human Small Airway Epithelium.
- Author
-
Yang J, Zuo WL, Fukui T, Chao I, Gomi K, Lee B, Staudt MR, Kaner RJ, Strulovici-Barel Y, Salit J, Crystal RG, and Shaykhiev R
- Subjects
- Adult, Epithelium physiopathology, Female, Humans, Male, Lung physiopathology, Pulmonary Disease, Chronic Obstructive physiopathology, Smoking physiopathology
- Abstract
Rationale: Small airways are the primary site of pathologic changes in chronic obstructive pulmonary disease (COPD), the major smoking-induced lung disorder., Objectives: On the basis of the concept of proximal-distal patterning that determines regional specialization of the airway epithelium during lung development, we hypothesized that a similar program operates in the adult human lung being altered by smoking, leading to decreased regional identity of the small airway epithelium (SAE)., Methods: The proximal and distal airway signatures were identified by comparing the transcriptomes of large and small airway epithelium samples obtained by bronchoscopy from healthy nonsmokers. The expression of these signatures was evaluated in the SAE of healthy smokers and smokers with COPD compared with that of healthy nonsmokers. The capacity of airway basal stem cells (BCs) to maintain region-associated phenotypes was evaluated using the air-liquid interface model., Measurements and Main Results: The distal and proximal airway signatures, containing 134 and 233 genes, respectively, were identified. These signatures included known developmental regulators of airway patterning, as well as novel regulators such as epidermal growth factor receptor, which was associated with the proximal airway phenotype. In the SAE of smokers with COPD, there was a dramatic smoking-dependent loss of the regional transcriptome identity with concomitant proximalization. This repatterning phenotype was reproduced by stimulating SAE BCs with epidermal growth factor, which was up-regulated in the SAE of smokers, during differentiation of SAE BCs in vitro., Conclusions: Smoking-induced global distal-to-proximal reprogramming of the SAE represents a novel pathologic feature of COPD and is mediated by exaggerated epidermal growth factor/epidermal growth factor receptor signaling in SAE BCs.
- Published
- 2017
- Full Text
- View/download PDF
20. EGF-Amphiregulin Interplay in Airway Stem/Progenitor Cells Links the Pathogenesis of Smoking-Induced Lesions in the Human Airway Epithelium.
- Author
-
Zuo WL, Yang J, Gomi K, Chao I, Crystal RG, and Shaykhiev R
- Subjects
- Adult, Airway Remodeling, Cell Differentiation, Cell Proliferation, Cilia metabolism, Down-Regulation, ErbB Receptors metabolism, Female, Humans, Hyperplasia, Male, Stem Cells metabolism, Up-Regulation, Amphiregulin metabolism, Epidermal Growth Factor metabolism, Respiratory Mucosa pathology, Smoking adverse effects, Stem Cells pathology
- Abstract
The airway epithelium of cigarette smokers undergoes dramatic remodeling with hyperplasia of basal cells (BC) and mucus-producing cells, squamous metaplasia, altered ciliated cell differentiation and decreased junctional barrier integrity, relevant to chronic obstructive pulmonary disease and lung cancer. In this study, we show that epidermal growth factor receptor (EGFR) ligand amphiregulin (AREG) is induced by smoking in human airway epithelium as a result of epidermal growth factor (EGF)-driven squamous differentiation of airway BC stem/progenitor cells. In turn, AREG induced a unique EGFR activation pattern in human airway BC, distinct from that evoked by EGF, leading to BC- and mucous hyperplasia, altered ciliated cell differentiation and impaired barrier integrity. Further, AREG promoted its own expression and suppressed expression of EGF, establishing an autonomous self-amplifying signaling loop in airway BC relevant for promotion of EGF-independent hyperplastic phenotypes. Thus, EGF-AREG interplay in airway BC stem/progenitor cells is one of the mechanisms that mediates the interconnected pathogenesis of all major smoking-induced lesions in the human airway epithelium. Stem Cells 2017;35:824-837., (© 2016 AlphaMed Press.)
- Published
- 2017
- Full Text
- View/download PDF
21. Pulmonary Abnormalities in Young, Light-Use Waterpipe (Hookah) Smokers.
- Author
-
Strulovici-Barel Y, Shaykhiev R, Salit J, Deeb RS, Krause A, Kaner RJ, Vincent TL, Agosto-Perez F, Wang G, Hollmann C, Shanmugam V, Almulla AM, Sattar H, Mahmoud M, Mezey JG, Gross SS, Staudt MR, Walters MS, and Crystal RG
- Subjects
- Adult, Carbon Monoxide analysis, Carboxyhemoglobin analysis, Case-Control Studies, Cell-Derived Microparticles drug effects, Cotinine urine, Cough etiology, Cough microbiology, Epithelial Cells drug effects, Female, Forced Expiratory Volume physiology, Humans, Male, Nicotine urine, Pulmonary Alveoli cytology, Pulmonary Alveoli drug effects, Sputum chemistry, Sputum drug effects, Thorax diagnostic imaging, Tomography, X-Ray Computed, Young Adult, Lung pathology, Lung physiopathology, Pulmonary Diffusing Capacity, Smoking adverse effects, Tobacco Use Disorder complications, Transcriptome drug effects
- Abstract
Rationale: Waterpipes, also called hookahs, are currently used by millions of people worldwide. Despite the increasing use of waterpipe smoking, there is limited data on the health effects of waterpipe smoking and there are no federal regulations regarding its use., Objectives: To assess the effects of waterpipe smoking on the human lung using clinical and biological parameters in young, light-use waterpipe smokers., Methods: We assessed young, light-use, waterpipe-only smokers in comparison with lifelong nonsmokers using clinical parameters of cough and sputum scores, lung function, and chest high-resolution computed tomography as well as biological parameters of lung epithelial lining fluid metabolome, small airway epithelial (SAE) cell differential and transcriptome, alveolar macrophage transcriptome, and plasma apoptotic endothelial cell microparticles., Measurements and Main Results: Compared with nonsmokers, waterpipe smokers had more cough and sputum as well as a lower lung diffusing capacity, abnormal epithelial lining fluid metabolome profile, increased proportions of SAE secretory and intermediate cells, reduced proportions of SAE ciliated and basal cells, markedly abnormal SAE and alveolar macrophage transcriptomes, and elevated levels of apoptotic endothelial cell microparticles., Conclusions: Young, light-use, waterpipe-only smokers have a variety of abnormalities in multiple lung-related biological and clinical parameters, suggesting that even limited waterpipe use has broad consequences on human lung biology and health. We suggest that large epidemiological studies should be initiated to investigate the harmful effects of waterpipe smoking.
- Published
- 2016
- Full Text
- View/download PDF
22. POU2AF1 Functions in the Human Airway Epithelium To Regulate Expression of Host Defense Genes.
- Author
-
Zhou H, Brekman A, Zuo WL, Ou X, Shaykhiev R, Agosto-Perez FJ, Wang R, Walters MS, Salit J, Strulovici-Barel Y, Staudt MR, Kaner RJ, Mezey JG, Crystal RG, and Wang G
- Subjects
- Cell Differentiation, Cluster Analysis, Epithelial Cells metabolism, Gene Expression Profiling, Humans, Respiratory Mucosa cytology, Smoking adverse effects, Gene Expression Regulation, Immunity genetics, Respiratory Mucosa immunology, Respiratory Mucosa metabolism, Trans-Activators genetics, Trans-Activators metabolism
- Abstract
In the process of seeking novel lung host defense regulators by analyzing genome-wide RNA sequence data from normal human airway epithelium, we detected expression of POU domain class 2-associating factor 1 (POU2AF1), a known transcription cofactor previously thought to be expressed only in lymphocytes. Lymphocyte contamination of human airway epithelial samples obtained by bronchoscopy and brushing was excluded by immunohistochemistry staining, the observation of upregulation of POU2AF1 in purified airway basal stem/progenitor cells undergoing differentiation, and analysis of differentiating single basal cell clones. Lentivirus-mediated upregulation of POU2AF1 in airway basal cells induced upregulation of host defense genes, including MX1, IFIT3, IFITM, and known POU2AF1 downstream genes HLA-DRA, ID2, ID3, IL6, and BCL6. Interestingly, expression of these genes paralleled changes of POU2AF1 expression during airway epithelium differentiation in vitro, suggesting POU2AF1 helps to maintain a host defense tone even in pathogen-free condition. Cigarette smoke, a known risk factor for airway infection, suppressed POU2AF1 expression both in vivo in humans and in vitro in human airway epithelial cultures, accompanied by deregulation of POU2AF1 downstream genes. Finally, enhancing POU2AF1 expression in human airway epithelium attenuated the suppression of host defense genes by smoking. Together, these findings suggest a novel function of POU2AF1 as a potential regulator of host defense genes in the human airway epithelium., (Copyright © 2016 by The American Association of Immunologists, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
23. Multitasking basal cells: combining stem cell and innate immune duties.
- Author
-
Shaykhiev R
- Subjects
- Bacteria immunology, Basement Membrane physiology, Bronchi immunology, Cell Differentiation, Epithelial Cells cytology, ErbB Receptors metabolism, Humans, Lung microbiology, Phenotype, Regeneration, Signal Transduction, Trachea immunology, Immunity, Innate immunology, Lung immunology, Stem Cells cytology
- Published
- 2015
- Full Text
- View/download PDF
24. Cilia dysfunction in lung disease.
- Author
-
Tilley AE, Walters MS, Shaykhiev R, and Crystal RG
- Subjects
- Animals, Axoneme physiology, Disease Models, Animal, Humans, Mice, Microtubules physiology, Mucociliary Clearance physiology, Cilia physiology, Ciliary Motility Disorders physiopathology, Lung Diseases physiopathology, Respiratory Mucosa physiopathology
- Abstract
A characteristic feature of the human airway epithelium is the presence of ciliated cells bearing motile cilia, specialized cell surface projections containing axonemes composed of microtubules and dynein arms, which provide ATP-driven motility. In the airways, cilia function in concert with airway mucus to mediate the critical function of mucociliary clearance, cleansing the airways of inhaled particles and pathogens. The prototypical disorder of respiratory cilia is primary ciliary dyskinesia, an inherited disorder that leads to impaired mucociliary clearance, to repeated chest infections, and to the progressive destruction of lung architecture. Numerous acquired lung diseases are also marked by abnormalities in both cilia structure and function. In this review we summarize current knowledge regarding airway ciliated cells and cilia, how they function to maintain a healthy epithelium, and how disorders of cilia structure and function contribute to inherited and acquired lung disease.
- Published
- 2015
- Full Text
- View/download PDF
25. Early events in the pathogenesis of chronic obstructive pulmonary disease. Smoking-induced reprogramming of airway epithelial basal progenitor cells.
- Author
-
Shaykhiev R and Crystal RG
- Subjects
- Cell Differentiation, Cytokines biosynthesis, Humans, Phenotype, Pulmonary Disease, Chronic Obstructive metabolism, Pulmonary Disease, Chronic Obstructive pathology, Respiratory Mucosa, Respiratory System metabolism, Time Factors, Cytokines genetics, DNA genetics, Gene Expression Regulation, Pulmonary Disease, Chronic Obstructive genetics, Respiratory System pathology, Smoking adverse effects, Stem Cells physiology
- Abstract
The airway epithelium is the primary site of the earliest pathologic changes induced by smoking, contributing to the development of chronic obstructive pulmonary disease (COPD). The normal human airway epithelium is composed of several major cell types, including differentiated ciliated and secretory cells, intermediate undifferentiated cells, and basal cells (BC). BC contain the stem/progenitor cell population responsible for maintenance of the normally differentiated airway epithelium. Although inflammatory and immune processes play a significant role in the pathogenesis of COPD, the earliest lesions include hyperplasia of the BC population, suggesting that the disease may start with this cell type. Apart from BC hyperplasia, smoking induces a number of COPD-relevant airway epithelial remodeling phenotypes that are likely initiated in the BC population, including mucous cell hyperplasia, squamous cell metaplasia, epithelial-mesenchymal transition, altered ciliated and nonmucous secretory cell differentiation, and suppression of junctional barrier integrity. Significant progress has been recently made in understanding the biology of human airway BC, including gene expression features, stem/progenitor, and other functions, including interaction with other airway cell types. Accumulating evidence suggests that human airway BC function as both sensors and cellular sources of various cytokines and growth factors relevant to smoking-associated airway injury, as well as the origin of various molecular and histological phenotypes relevant to the pathogenesis of COPD. In the context of these considerations, we suggest that early BC-specific smoking-induced molecular changes are critical to the pathogenesis of COPD, and these represent a candidate target for novel therapeutic approaches to prevent COPD progression in susceptible individuals.
- Published
- 2014
- Full Text
- View/download PDF
26. Airway Basal stem/progenitor cells have diminished capacity to regenerate airway epithelium in chronic obstructive pulmonary disease.
- Author
-
Staudt MR, Buro-Auriemma LJ, Walters MS, Salit J, Vincent T, Shaykhiev R, Mezey JG, Tilley AE, Kaner RJ, Ho MW, and Crystal RG
- Subjects
- Case-Control Studies, Cells, Cultured, DNA Methylation, Humans, Pulmonary Disease, Chronic Obstructive genetics, Cell Differentiation, Pulmonary Disease, Chronic Obstructive physiopathology, Respiratory Mucosa physiopathology, Stem Cells physiology
- Published
- 2014
- Full Text
- View/download PDF
27. Smoking dysregulates the human airway basal cell transcriptome at COPD risk locus 19q13.2.
- Author
-
Ryan DM, Vincent TL, Salit J, Walters MS, Agosto-Perez F, Shaykhiev R, Strulovici-Barel Y, Downey RJ, Buro-Auriemma LJ, Staudt MR, Hackett NR, Mezey JG, and Crystal RG
- Subjects
- Adult, DNA Copy Number Variations genetics, DNA Methylation, Genome-Wide Association Study, Humans, Oligonucleotide Array Sequence Analysis, Pulmonary Disease, Chronic Obstructive chemically induced, Pulmonary Disease, Chronic Obstructive pathology, Respiratory Mucosa drug effects, Respiratory Mucosa pathology, Smoking genetics, Biomarkers metabolism, Chromosomes, Human, Pair 19 genetics, Endothelial Cells metabolism, Gene Expression Profiling, Genetic Loci, Pulmonary Disease, Chronic Obstructive genetics, Respiratory Mucosa metabolism, Smoking adverse effects
- Abstract
Genome-wide association studies (GWAS) and candidate gene studies have identified a number of risk loci associated with the smoking-related disease COPD, a disorder that originates in the airway epithelium. Since airway basal cell (BC) stem/progenitor cells exhibit the earliest abnormalities associated with smoking (hyperplasia, squamous metaplasia), we hypothesized that smoker BC have a dysregulated transcriptome, enriched, in part, at known GWAS/candidate gene loci. Massive parallel RNA sequencing was used to compare the transcriptome of BC purified from the airway epithelium of healthy nonsmokers (n = 10) and healthy smokers (n = 7). The chromosomal location of the differentially expressed genes was compared to loci identified by GWAS to confer risk for COPD. Smoker BC have 676 genes differentially expressed compared to nonsmoker BC, dominated by smoking up-regulation. Strikingly, 166 (25%) of these genes are located on chromosome 19, with 13 localized to 19q13.2 (p<10⁻⁴ compared to chance), including 4 genes (NFKBIB, LTBP4, EGLN2 and TGFB1) associated with risk for COPD. These observations provide the first direct connection between known genetic risks for smoking-related lung disease and airway BC, the population of lung cells that undergo the earliest changes associated with smoking.
- Published
- 2014
- Full Text
- View/download PDF
28. Basal cell origins of smoking-induced airway epithelial disorders.
- Author
-
Shaykhiev R and Crystal RG
- Subjects
- Humans, Cell Differentiation physiology, Epidermal Growth Factor metabolism, Epithelial Cells metabolism, Epithelial-Mesenchymal Transition physiology, ErbB Receptors metabolism, Respiratory Mucosa pathology, Smoking adverse effects
- Published
- 2014
- Full Text
- View/download PDF
29. Lung adenocarcinoma subtypes based on expression of human airway basal cell genes.
- Author
-
Fukui T, Shaykhiev R, Agosto-Perez F, Mezey JG, Downey RJ, Travis WD, and Crystal RG
- Subjects
- Adenocarcinoma mortality, Adenocarcinoma of Lung, Aged, Biopsy, Cell Differentiation, Cohort Studies, Epithelial Cells pathology, ErbB Receptors genetics, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Lung Neoplasms mortality, Male, Middle Aged, Phenotype, Principal Component Analysis, Proportional Hazards Models, Transcriptome, ras Proteins genetics, Adenocarcinoma classification, Adenocarcinoma genetics, Lung Neoplasms classification, Lung Neoplasms genetics, Neoplasms, Basal Cell metabolism
- Abstract
Lung cancer, including lung adenocarcinoma, is a heterogeneous disease, which evolves from molecular alterations in the airway epithelium. This study explores whether a subtype of lung adenocarcinomas expresses the unique molecular features of human airway basal cells (BCs), and how expression of the airway BC features correlates with the molecular, pathological and clinical phenotype of lung adenocarcinoma. Three independent lung adenocarcinoma data sets were analysed for expression of genes that constitute the airway BC signature. Expression of the BC signature in lung adenocarcinoma was then correlated to clinical and biological parameters. Remarkable enrichment of airway BC signature genes was found in lung adenocarcinomas. A subset of lung adenocarcinomas (BC-high adenocarcinoma) exhibited high expression of BC signature genes in association with poorer tumour grade, higher frequency of vascular invasion and shorter survival than adenocarcinomas with lower expression of these genes. At the molecular level, BC-high adenocarcinomas displayed a higher frequency of KRAS mutations, activation of transcriptional networks and pathways related to cell cycle, extracellular matrix organisation, and a distinct differentiation pattern with suppression of ciliated and exocrine bronchiolar cell (Clara cell)-related genes. Activation of the airway BC programme is a molecular feature of a distinct, aggressive subtype of lung adenocarcinoma.
- Published
- 2013
- Full Text
- View/download PDF
30. Airway basal cells of healthy smokers express an embryonic stem cell signature relevant to lung cancer.
- Author
-
Shaykhiev R, Wang R, Zwick RK, Hackett NR, Leung R, Moore MA, Sima CS, Chao IW, Downey RJ, Strulovici-Barel Y, Salit J, and Crystal RG
- Subjects
- Adenocarcinoma genetics, Adenocarcinoma pathology, Adenocarcinoma of Lung, Animals, Cell Line, Tumor, Epithelium metabolism, Epithelium pathology, Gene Expression Regulation, Neoplastic, Humans, Lung metabolism, Mice, Multivariate Analysis, Phenotype, Proportional Hazards Models, Survival Analysis, Tumor Suppressor Protein p53 metabolism, Embryonic Stem Cells metabolism, Gene Expression Profiling, Lung pathology, Lung Neoplasms genetics, Lung Neoplasms pathology, Smoking genetics, Smoking pathology
- Abstract
Activation of the human embryonic stem cell (hESC) signature genes has been observed in various epithelial cancers. In this study, we found that the hESC signature is selectively induced in the airway basal stem/progenitor cell population of healthy smokers (BC-S), with a pattern similar to that activated in all major types of human lung cancer. We further identified a subset of 6 BC-S hESC genes, whose coherent overexpression in lung adenocarcinoma (AdCa) was associated with reduced lung function, poorer differentiation grade, more advanced tumor stage, remarkably shorter survival, and higher frequency of TP53 mutations. BC-S shared with hESC and a considerable subset of lung carcinomas a common TP53 inactivation molecular pattern which strongly correlated with the BC-S hESC gene expression. These data provide transcriptome-based evidence that smoking-induced reprogramming of airway BC toward the hESC-like phenotype might represent a common early molecular event in the development of aggressive lung carcinomas in humans., (© AlphaMed Press.)
- Published
- 2013
- Full Text
- View/download PDF
31. Smoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancer.
- Author
-
Shaykhiev R, Sackrowitz R, Fukui T, Zuo WL, Chao IW, Strulovici-Barel Y, Downey RJ, and Crystal RG
- Subjects
- Adenocarcinoma etiology, Adenocarcinoma mortality, Adenocarcinoma pathology, Adenocarcinoma of Lung, Adult, Carcinoma, Squamous Cell etiology, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Cells, Cultured, Chemokines, CXC agonists, Chemokines, CXC immunology, Complex Mixtures isolation & purification, Epithelial Cells cytology, Epithelial Cells drug effects, Epithelial Cells immunology, Female, Gene Expression, Genome-Wide Association Study, Humans, Lung Neoplasms etiology, Lung Neoplasms mortality, Lung Neoplasms pathology, Male, Middle Aged, Pulmonary Disease, Chronic Obstructive etiology, Pulmonary Disease, Chronic Obstructive mortality, Pulmonary Disease, Chronic Obstructive pathology, Respiratory Mucosa immunology, Respiratory Mucosa pathology, Respiratory System immunology, Respiratory System pathology, Stem Cells cytology, Stem Cells drug effects, Stem Cells immunology, Survival Analysis, Adenocarcinoma genetics, Carcinoma, Squamous Cell genetics, Chemokines, CXC genetics, Complex Mixtures pharmacology, Lung Neoplasms genetics, Pulmonary Disease, Chronic Obstructive genetics, Smoking adverse effects
- Abstract
CXCL14, a recently described epithelial cytokine, plays putative multiple roles in inflammation and carcinogenesis. In the context that chronic obstructive pulmonary disease (COPD) and lung cancer are both smoking-related disorders associated with airway epithelial disorder and inflammation, we hypothesized that the airway epithelium responds to cigarette smoking with altered CXCL14 gene expression, contributing to the disease-relevant phenotype. Using genome-wide microarrays with subsequent immunohistochemical analysis, the data demonstrate that the expression of CXCL14 is up-regulated in the airway epithelium of healthy smokers and further increased in COPD smokers, especially within hyperplastic/metaplastic lesions, in association with multiple genes relevant to epithelial structural integrity and cancer. In vitro experiments revealed that the expression of CXCL14 is induced in the differentiated airway epithelium by cigarette smoke extract, and that epidermal growth factor mediates CXCL14 up-regulation in the airway epithelium through its effects on the basal stem/progenitor cell population. Analyses of two independent lung cancer cohorts revealed a dramatic up-regulation of CXCL14 expression in adenocarcinoma and squamous-cell carcinoma. High expression of the COPD-associated CXCL14-correlating cluster of genes was linked in lung adenocarcinoma with poor survival. These data suggest that the smoking-induced expression of CXCL14 in the airway epithelium represents a novel potential molecular link between smoking-associated airway epithelial injury, COPD, and lung cancer.
- Published
- 2013
- Full Text
- View/download PDF
32. EGF shifts human airway basal cell fate toward a smoking-associated airway epithelial phenotype.
- Author
-
Shaykhiev R, Zuo WL, Chao I, Fukui T, Witover B, Brekman A, and Crystal RG
- Subjects
- Blotting, Western, Cell Differentiation drug effects, Epidermal Growth Factor pharmacology, Epithelial Cells drug effects, Epithelial-Mesenchymal Transition drug effects, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Microarray Analysis, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Cell Differentiation physiology, Epidermal Growth Factor metabolism, Epithelial Cells metabolism, Epithelial-Mesenchymal Transition physiology, ErbB Receptors metabolism, Respiratory Mucosa pathology, Smoking adverse effects
- Abstract
The airway epithelium of smokers acquires pathological phenotypes, including basal cell (BC) and/or goblet cell hyperplasia, squamous metaplasia, structural and functional abnormalities of ciliated cells, decreased number of secretoglobin (SCGB1A1)-expressing secretory cells, and a disordered junctional barrier. In this study, we hypothesized that smoking alters airway epithelial structure through modification of BC function via an EGF receptor (EGFR)-mediated mechanism. Analysis of the airway epithelium revealed that EGFR is enriched in airway BCs, whereas its ligand EGF is induced by smoking in ciliated cells. Exposure of BCs to EGF shifted the BC differentiation program toward the squamous and epithelial-mesenchymal transition-like phenotypes with down-regulation of genes related to ciliogenesis, secretory differentiation, and markedly reduced junctional barrier integrity, mimicking the abnormalities present in the airways of smokers in vivo. These data suggest that activation of EGFR in airway BCs by smoking-induced EGF represents a unique mechanism whereby smoking can alter airway epithelial differentiation and barrier function.
- Published
- 2013
- Full Text
- View/download PDF
33. Innate immunity and chronic obstructive pulmonary disease: a mini-review.
- Author
-
Shaykhiev R and Crystal RG
- Subjects
- Aging immunology, Antioxidants metabolism, Dendritic Cells immunology, Disease Progression, Humans, Immunomodulation, Inflammation immunology, Killer Cells, Natural immunology, Lung immunology, Lung microbiology, Macrophages, Alveolar immunology, Neutrophils immunology, Pulmonary Disease, Chronic Obstructive etiology, Pulmonary Disease, Chronic Obstructive therapy, Respiratory Mucosa immunology, Respiratory Tract Infections etiology, Smoking adverse effects, Smoking immunology, Immunity, Innate, Pulmonary Disease, Chronic Obstructive immunology
- Abstract
Chronic obstructive pulmonary disease (COPD), a major smoking-associated lung disorder characterized by progressive irreversible airflow limitation, affects >200 million people worldwide. Individuals with COPD have increased susceptibility to respiratory infections, resulting in exacerbations of the disease. A growing body of evidence indicates that multiple host defense mechanisms, such as those provided by the airway epithelial barrier and innate immune cells, including alveolar macrophages, neutrophils, dendritic cells and natural killer cells, are broadly suppressed in COPD in a smoking-dependent manner. Inactivation of the innate immune system observed in COPD smokers is remarkably similar to the immunosenescence phenotype associated with aging. As a consequence of defective innate immune defense, the lungs of COPD smokers are frequently colonized with pathogens and commonly develop bacterial and viral infections, which cause secondary inflammation, a major driver of the disease progression. In this review, we summarize the evidence from human studies related to disordering of the innate immune system in COPD, discuss possible relationships between those changes and aging, and provide insights into potential therapeutic strategies aimed at the prevention of COPD progression via normalization of the disordered innate immune mechanisms., (© 2013 S. Karger AG, Basel.)
- Published
- 2013
- Full Text
- View/download PDF
34. The human airway epithelial basal cell transcriptome.
- Author
-
Hackett NR, Shaykhiev R, Walters MS, Wang R, Zwick RK, Ferris B, Witover B, Salit J, and Crystal RG
- Subjects
- Cell Differentiation genetics, Cell Differentiation physiology, Cells, Cultured, Humans, Signal Transduction genetics, Signal Transduction physiology, Epithelial Cells cytology, Epithelial Cells metabolism, Gene Expression Profiling methods, Respiratory System cytology
- Abstract
Background: The human airway epithelium consists of 4 major cell types: ciliated, secretory, columnar and basal cells. During natural turnover and in response to injury, the airway basal cells function as stem/progenitor cells for the other airway cell types. The objective of this study is to better understand human airway epithelial basal cell biology by defining the gene expression signature of this cell population., Methodology/principal Findings: Bronchial brushing was used to obtain airway epithelium from healthy nonsmokers. Microarrays were used to assess the transcriptome of basal cells purified from the airway epithelium in comparison to the transcriptome of the differentiated airway epithelium. This analysis identified the "human airway basal cell signature" as 1,161 unique genes with >5-fold higher expression level in basal cells compared to differentiated epithelium. The basal cell signature was suppressed when the basal cells differentiated into a ciliated airway epithelium in vitro. The basal cell signature displayed overlap with genes expressed in basal-like cells from other human tissues and with that of murine airway basal cells. Consistent with self-modulation as well as signaling to other airway cell types, the human airway basal cell signature was characterized by genes encoding extracellular matrix components, growth factors and growth factor receptors, including genes related to the EGF and VEGF pathways. Interestingly, while the basal cell signature overlaps that of basal-like cells of other organs, the human airway basal cell signature has features not previously associated with this cell type, including a unique pattern of genes encoding extracellular matrix components, G protein-coupled receptors, neuroactive ligands and receptors, and ion channels., Conclusion/significance: The human airway epithelial basal cell signature identified in the present study provides novel insights into the molecular phenotype and biology of the stem/progenitor cells of the human airway epithelium.
- Published
- 2011
- Full Text
- View/download PDF
35. Modulation of cystatin A expression in human airway epithelium related to genotype, smoking, COPD, and lung cancer.
- Author
-
Butler MW, Fukui T, Salit J, Shaykhiev R, Mezey JG, Hackett NR, and Crystal RG
- Subjects
- Adenocarcinoma genetics, Adenocarcinoma metabolism, Adenocarcinoma of Lung, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell metabolism, Cystatin A genetics, Gene Expression, Genotype, Humans, Lung Neoplasms genetics, Polymorphism, Single Nucleotide, Pulmonary Disease, Chronic Obstructive genetics, Smoking genetics, Cystatin A biosynthesis, Lung Neoplasms metabolism, Pulmonary Disease, Chronic Obstructive metabolism, Respiratory Mucosa metabolism, Smoking metabolism
- Abstract
The cathepsin inhibitor Cystatin A (CSTA) has antiapoptotic properties linked with neoplastic changes in squamous cell epithelium, where it has been proposed as a diagnostic and prognostic marker of lung cancer. Notably, cystatin A is upregulated in dysplastic epithelium, prompting us to hypothesize that it might be modulated in chronic obstructive pulmonary disease (COPD), a small airway epithelial (SAE) disorder that is a risk factor for non-small cell lung cancer (NSCLC) in a subset of smokers. Here we report that genetic variation, smoking, and COPD can all elevate levels of CSTA expression in lung small airway epithelia, with still further upregulation in squamous cell carcinoma (SCC), an NSCLC subtype. We examined SAE gene expression in 178 individuals, including healthy nonsmokers (n = 60), healthy smokers (n = 82), and COPD smokers (n = 36), with corresponding large airway epithelium (LAE) data included in a subset of subjects (n = 52). Blood DNA was genotyped by SNP microarray. Twelve SNPs upstream of the CSTA gene were found to associate with its expression in SAE. Levels were higher in COPD smokers than in healthy smokers, who, in turn, had higher levels than nonsmokers. CSTA gene expression in LAE was also smoking-responsive. Using publicly available NSCLC expression data we also found that CSTA was upregulated in SCC versus LAE and downregulated in adenocarcinoma versus smoke-exposed SAE. All phenotypes were associated with different proportional expression of CSTA to cathepsins. Our findings establish that genetic variability, smoking, and COPD all influence CSTA expression, as does SCC, supporting the concept that CSTA may make pivotal contributions to NSCLC pathogenesis in both early and late stages of disease development.
- Published
- 2011
- Full Text
- View/download PDF
36. Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome?
- Author
-
Dvorak A, Tilley AE, Shaykhiev R, Wang R, and Crystal RG
- Subjects
- Adult, Cell Cycle genetics, Cell Proliferation, Cells, Cultured, Cilia genetics, Cytoskeleton genetics, Female, Gene Expression Regulation, Humans, Immunity, Humoral genetics, Male, Signal Transduction genetics, Young Adult, Air, Gene Expression Profiling, Respiratory Mucosa cytology, Respiratory Mucosa metabolism, Tissue Culture Techniques
- Abstract
Human airway epithelial cells cultured in vitro at the air-liquid interface (ALI) form a pseudostratified epithelium that forms tight junctions and cilia, and produces mucin. These cells are widely used in models of differentiation, injury, and repair. To assess how closely the transcriptome of ALI epithelium matches that of in vivo airway epithelial cells, we used microarrays to compare the transcriptome of human large airway epithelial cells cultured at the ALI with the transcriptome of large airway epithelium obtained via bronchoscopy and brushing. Gene expression profiling showed that global gene expression correlated well between ALI cells and brushed cells, but with some differences. Gene expression patterns mirrored differences in proportions of cell types (ALIs have higher percentages of basal cells, whereas brushed cells have higher percentages of ciliated cells), that is, ALI cells expressed higher levels of basal cell-related genes, and brushed cells expressed higher levels of cilia-related genes. Pathway analysis showed that ALI cells had increased expression of cell cycle and proliferation genes, whereas brushed cells had increased expression of cytoskeletal organization and humoral immune response genes. Overall, ALI cells provide a good representation of the in vivo airway epithelial transcriptome, but for some biologic questions, the differences between in vitro and in vivo environments need to be considered.
- Published
- 2011
- Full Text
- View/download PDF
37. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo.
- Author
-
Shaykhiev R, Otaki F, Bonsu P, Dang DT, Teater M, Strulovici-Barel Y, Salit J, Harvey BG, and Crystal RG
- Subjects
- Cells, Cultured, Epithelial Cells metabolism, Epithelial Cells ultrastructure, Gene Expression Profiling, Humans, Intercellular Junctions genetics, Intercellular Junctions metabolism, Oligonucleotide Array Sequence Analysis, Permeability, Pulmonary Disease, Chronic Obstructive genetics, Pulmonary Disease, Chronic Obstructive metabolism, Pulmonary Disease, Chronic Obstructive pathology, Signal Transduction drug effects, Down-Regulation drug effects, Epithelial Cells drug effects, Intercellular Junctions drug effects, Respiratory Mucosa drug effects, Smoking adverse effects, Transcription, Genetic drug effects
- Abstract
The apical junctional complex (AJC), composed of tight and adherens junctions, maintains epithelial barrier function. Since cigarette smoking and chronic obstructive pulmonary disease (COPD), the major smoking-induced disease, are associated with increased lung epithelial permeability, we hypothesized that smoking alters the transcriptional program regulating airway epithelial AJC integrity. Transcriptome analysis revealed global down-regulation of physiological AJC gene expression in the airway epithelium of healthy smokers (n = 59) compared to nonsmokers (n = 53) in association with changes in canonical epithelial differentiation pathways such as PTEN signaling accompanied by induction of cancer-related AJC components. The overall expression of AJC-related genes was further decreased in COPD smokers (n = 23). Exposure of airway epithelial cells to cigarette smoke extract in vitro resulted in down-regulation of several AJC genes paralleled by decreased transepithelial resistance. Thus, cigarette smoking induces transcriptional reprogramming of airway epithelial AJC architecture from its physiological pattern necessary for barrier function toward a disease-associated molecular phenotype.
- Published
- 2011
- Full Text
- View/download PDF
38. The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS.
- Author
-
Shaykhiev R, Sierigk J, Herr C, Krasteva G, Kummer W, and Bals R
- Subjects
- Antimicrobial Cationic Peptides, Biological Transport drug effects, Cell Line, Cells, Cultured, Endocytosis drug effects, Enzyme-Linked Immunosorbent Assay, ErbB Receptors metabolism, Fluorescence Resonance Energy Transfer, Humans, Microscopy, Confocal, Signal Transduction drug effects, Cathelicidins pharmacology, Epithelial Cells drug effects, Epithelial Cells metabolism, Lipopolysaccharides metabolism, Lipopolysaccharides pharmacology, Lung cytology
- Abstract
Epithelial cells (ECs) are usually hyporesponsive to various microbial products. Detection of lipopolysaccharide (LPS), the major component of gram-negative bacteria, is impeded, at least in part, by intracellular sequestration of its receptor, Toll-like receptor-4 (TLR4). In this study, using human bronchial ECs (hBECs) as a model of mucosal epithelium, we tested the hypothesis that the human LPS-binding, membrane-active cationic host defense peptide cathelicidin LL-37 augments epithelial response to LPS by facilitating its delivery to TLR4-containing intracellular compartments. We found that LL-37 significantly increases uptake of LPS by ECs with subsequent targeting to cholera toxin subunit B-labeled structures and lysosomes. This uptake is peptide specific, dose and time dependent, and involves the endocytotic machinery, functional lipid rafts, and epidermal growth factor receptor signaling. Cathelicidin-dependent LPS internalization resulted in significant increased release of the inflammatory cytokines IL-6 and IL-8. This indicates that, in ECs, this peptide may replace LPS-binding protein functions. In polarized ECs, the effect of LL-37 was restricted to the basolateral compartment of the epithelial membrane, suggesting that LL-37-mediated activation of ECs by LPS may be relevant to disease conditions associated with damage to the epithelial barrier. In summary, our study identified a novel role of LL-37 in host-microbe interactions as a host factor that licenses mucosal ECs to respond to LPS.
- Published
- 2010
- Full Text
- View/download PDF
39. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease.
- Author
-
Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, O'Connor TP, and Crystal RG
- Subjects
- Adult, Bronchoalveolar Lavage Fluid cytology, Bronchoalveolar Lavage Fluid immunology, Female, Gene Expression Regulation immunology, Humans, Inflammation Mediators pharmacology, Lung immunology, Lung metabolism, Lung pathology, Macrophages, Alveolar classification, Macrophages, Alveolar metabolism, Male, Middle Aged, Nicotine administration & dosage, Oligonucleotide Array Sequence Analysis, Pulmonary Disease, Chronic Obstructive etiology, Cell Polarity immunology, Macrophages, Alveolar immunology, Macrophages, Alveolar pathology, Pulmonary Disease, Chronic Obstructive immunology, Pulmonary Disease, Chronic Obstructive pathology, Smoking immunology, Smoking pathology
- Abstract
When exposed to a specific microenvironment, macrophages acquire either M1- or M2-polarized phenotypes associated with inflammation and tissue remodeling, respectively. Alveolar macrophages (AM) directly interact with environmental stimuli such as cigarette smoke, the major risk factor for chronic obstructive pulmonary disease (COPD), a disease characterized by lung inflammation and remodeling. Transcriptional profiling of AM obtained by bronchoalveolar lavage of 24 healthy nonsmokers, 34 healthy smokers, and 12 COPD smokers was performed to test the hypothesis whether smoking alters AM polarization, resulting in a disease-relevant activation phenotype. The analysis revealed that AM of healthy smokers exhibited a unique polarization pattern characterized by substantial suppression of M1-related inflammatory/immune genes and induction of genes associated with various M2-polarization programs relevant to tissue remodeling and immunoregulation. Such reciprocal changes progressed with the development of COPD, with M1-related gene expression being most dramatically down-regulated (p < 0.0001 vs healthy nonsmokers, p < 0.002 vs healthy smokers). Results were confirmed with TaqMan real-time PCR and flow cytometry. Among progressively down-regulated M1-related genes were those encoding type I chemokines CXCL9, CXCL10, CXCL11, and CCL5. Progressive activation of M2-related program was characterized by induction of tissue remodeling and immunoregulatory genes such as matrix metalloproteinase (MMP)2, MMP7, and adenosine A3 receptor (ADORA3). Principal component analysis revealed that differential expression of polarization-related genes has substantial contribution to global AM phenotypes associated with smoking and COPD. In summary, the data provide transcriptome-based evidence that AM likely contribute to COPD pathogenesis in a noninflammatory manner due to their smoking-induced reprogramming toward M1-deactivated, partially M2-polarized macrophages.
- Published
- 2009
- Full Text
- View/download PDF
40. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival.
- Author
-
Shaykhiev R, Behr J, and Bals R
- Subjects
- Cells, Cultured, Epithelium growth & development, Epithelium pathology, Humans, Ligands, Signal Transduction, Staphylococcus aureus physiology, Toll-Like Receptor 2 metabolism, Toll-Like Receptor 5 metabolism, Wound Healing
- Abstract
Epithelial cells (ECs) continuously interact with microorganisms and detect their presence via different pattern-recognition receptors (PRRs) including Toll-like receptors (TLRs). Ligation of epithelial TLRs by pathogens is usually associated with the induction of pro-inflammatory mediators and antimicrobial factors. In this study, using human airway ECs as a model, we found that detection of microbial patterns via epithelial TLRs directly regulates tissue homeostasis. Staphylococcus aureus (S. aureus) and microbial patterns signaling via TLR2 and TLR5 induce a set of non-immune epithelial responses including cell migration, wound repair, proliferation, and survival of primary and cancerous ECs. Using small interfering RNA (siRNA) gene targeting, receptor-tyrosine kinase microarray and inhibition studies, we determined that TLR and the epidermal growth factor receptor (EGFR) mediate the stimulating effect of microbial patterns on epithelial repair. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. This effect is independent of hematopoietic and other cells as well as inflammatory cytokines suggesting that epithelia are able to regulate their integrity in an autonomous non-inflammatory manner by sensing microbes directly via TLRs.
- Published
- 2008
- Full Text
- View/download PDF
41. The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.
- Author
-
von Haussen J, Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R, Biesterfeld S, Aigner A, Czubayko F, and Bals R
- Subjects
- Animals, Antimicrobial Cationic Peptides analysis, Antimicrobial Cationic Peptides genetics, Cell Line, Tumor, ErbB Receptors physiology, Female, Humans, Mice, Mice, Inbred BALB C, Mice, Nude, RNA, Messenger analysis, Signal Transduction, Cathelicidins, Antimicrobial Cationic Peptides physiology, Growth Substances physiology, Lung Neoplasms pathology
- Abstract
Cancer development can be viewed as dysregulated repair. Antimicrobial peptides (AMPs) are effector molecules of the innate immune system with direct antimicrobial activity. Beside this host defence function several AMPs play a role in the regulation of inflammation and tissue repair. The aim of the present study was to investigate whether the human cathelicidin AMP LL-37/hCAP-18 is involved in the biology of lung cancer. Human cancer cell lines were found to express the human cathelicidin LL-37/hCAP-18 mRNA and peptide at different levels. Immunohistochemistry of human lung cancers showed that the peptide is expressed mostly in adenocarcinoma and squamous cell carcinoma. Application of exogenous LL-37 at low concentrations of 5ng/ml to cancer cell lines increased proliferation and growth of anchorage-independent colonies. At the molecular level, LL-37 induced phosphorylation of the epidermal growth factor receptor (EGFR) and activation of downstream MAP kinase signalling pathways. Lung cancer cell lines that stably overexpress the peptide by means of a doxycycline-regulated promoter system also showed a faster growth. When these cell lines were injected subcutaneously into nude mice, cathelicidin overexpression resulted in increased tumourigenicity and the formation of significantly larger tumours. In conclusion, cathelicidin is expressed in human lung cancers. The peptide activates tumour cells resulting in increased cell growth in vitro and in an animal model. The host defence peptide cathelicidin LL-37/hCAP-18 acts as growth factor for human lung cancer.
- Published
- 2008
- Full Text
- View/download PDF
42. The role of cathelicidin and defensins in pulmonary inflammatory diseases.
- Author
-
Herr C, Shaykhiev R, and Bals R
- Subjects
- Animals, Humans, Cathelicidins, Antimicrobial Cationic Peptides physiology, Defensins physiology, Pneumonia metabolism
- Abstract
Antimicrobial peptides (AMPs) protect the epithelia of mucosal organs like the respiratory or the gastrointestinal tract from invading microorganisms. As an integral part of the innate immune system they display antimicrobial activity against gram- and gram-negative bacteria as well as against fungi and enveloped and non-enveloped viruses. Besides their microbicidal effects they have important functions in the regulation of repair and inflammation. AMPs are sometimes referred to as 'alarmins' due to their ability to recruit, modulate and activate components of the immune system. In contrast, some AMPs suppress activation of the immune system. AMPs are also involved in tissue repair, cancer biology and angiogenesis. Based on their antimicrobial and immunomodulatoy functions, AMPs are probably involved in the pathogenesis of infectious and inflammatory diseases of the lung. Inborn or acquired deficiencies contribute to susceptibility to infection and colonisation. The potential pro-inflammatory role of AMPs contributes to the disease processes in inflammatory disorders such as asthma, chronic obstructive pulmonary disease, sepsis or pulmonary fibrosis. This review summarises the knowledge about the functions of AMPs in the pulmonary innate host defence system and their role in respiratory disease.
- Published
- 2007
- Full Text
- View/download PDF
43. Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis.
- Author
-
Shaykhiev R and Bals R
- Subjects
- Epithelial Cells immunology, Homeostasis immunology, Humans, Immunity, Leukocytes immunology, Membrane Proteins metabolism, Membrane Proteins physiology, Cell Communication immunology, Epithelial Cells physiology, Leukocytes physiology
- Abstract
Epithelial cells (ECs) cover the surfaces of the body such as skin, airways, or the intestinal tract and provide an important link between the outside environment and the body interior. Leukocytes play a critical role in immunity, as they are the predominant cell population involved in inflammation and the only cells providing adaptive immune response to pathogenic microorganisms. ECs and leukocytes form a complex network, which regulates processes such as host defense, immunity, inflammation, tissue repair, and cancer growth. One of the most critical functions of ECs is to keep up a barrier to the outside and to protect the sensitive immune system from continuous contact with external microorganisms. An appropriate response to wounding or danger involves not only killing of microbes but also regulation of tissue repair and reconstitution of the barrier system. Dysregulated response to damage represents a pathophysiological mechanism, which leads to autoimmunity, chronic inflammatory diseases, and cancer development. The networks described here are involved in virtually all diseases that take place at body surfaces. In this article, we develop a concept of epithelial barrier as a critical regulator of leukocyte function and discuss how host defense processes modulate epithelial homeostasis.
- Published
- 2007
- Full Text
- View/download PDF
44. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure.
- Author
-
Shaykhiev R, Beisswenger C, Kändler K, Senske J, Püchner A, Damm T, Behr J, and Bals R
- Subjects
- Antimicrobial Cationic Peptides genetics, Antimicrobial Cationic Peptides physiology, Antimicrobial Cationic Peptides toxicity, Base Sequence, Bronchi cytology, Bronchi injuries, Bronchi metabolism, Cell Line, Cell Proliferation drug effects, DNA, Complementary genetics, Epithelial Cells cytology, Epithelial Cells drug effects, Epithelial Cells metabolism, Gene Expression drug effects, Humans, Receptors, Formyl Peptide genetics, Receptors, Leukotriene B4, Receptors, Lipoxin genetics, Receptors, Purinergic P2 genetics, Signal Transduction drug effects, Wound Healing drug effects, Wound Healing genetics, Wound Healing physiology, Cathelicidins, Antimicrobial Cationic Peptides pharmacology, Bronchi drug effects
- Abstract
Antimicrobial peptides are endogenous antibiotics that directly inactivate microorganisms and in addition have a variety of receptor-mediated functions. LL-37/hCAP-18 is the only cathelicidin found in humans and is involved in angiogenesis and regulation of the innate immune system. The aim of the present study was to characterize the role of the peptide LL-37 in the regulation of wound closure of the airway epithelium in the cell line NCI-H292 and primary airway epithelial cells. LL-37 stimulated healing of mechanically induced wounds in monolayers of the cell line and in differentiated primary airway epithelium. This effect was detectable at concentrations of 5 mug/ml in NCI-H292 and 1 mug/ml in primary cells. The effect of LL-37 on wound healing was dependent on the presence of serum. LL-37 induced cell proliferation and migration of NCI-H292 cells. Inhibitor studies in the wound closure and proliferation assays indicated that the effects caused by LL-37 are mediated through epidermal growth factor receptor, a G protein-coupled receptor, and MAP/extracellular regulated kinase. In conclusion, LL-37 induces wound healing, proliferation, and migration of airway epithelial cells. The peptide is likely involved in the regulation of tissue homeostasis in the airways.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.